1. Home
  2. KRYS vs TDS Comparison

KRYS vs TDS Comparison

Compare KRYS & TDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • TDS
  • Stock Information
  • Founded
  • KRYS 2015
  • TDS 1968
  • Country
  • KRYS United States
  • TDS United States
  • Employees
  • KRYS N/A
  • TDS N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • TDS Telecommunications Equipment
  • Sector
  • KRYS Health Care
  • TDS Telecommunications
  • Exchange
  • KRYS Nasdaq
  • TDS Nasdaq
  • Market Cap
  • KRYS 4.3B
  • TDS 4.4B
  • IPO Year
  • KRYS 2017
  • TDS N/A
  • Fundamental
  • Price
  • KRYS $155.71
  • TDS $38.74
  • Analyst Decision
  • KRYS Strong Buy
  • TDS Buy
  • Analyst Count
  • KRYS 9
  • TDS 2
  • Target Price
  • KRYS $203.22
  • TDS $52.00
  • AVG Volume (30 Days)
  • KRYS 295.3K
  • TDS 1.0M
  • Earning Date
  • KRYS 11-03-2025
  • TDS 10-31-2025
  • Dividend Yield
  • KRYS N/A
  • TDS 0.41%
  • EPS Growth
  • KRYS 36.22
  • TDS N/A
  • EPS
  • KRYS 4.91
  • TDS N/A
  • Revenue
  • KRYS $359,205,000.00
  • TDS $4,805,000,000.00
  • Revenue This Year
  • KRYS $34.33
  • TDS N/A
  • Revenue Next Year
  • KRYS $47.84
  • TDS $0.29
  • P/E Ratio
  • KRYS $31.68
  • TDS N/A
  • Revenue Growth
  • KRYS 116.08
  • TDS N/A
  • 52 Week Low
  • KRYS $122.80
  • TDS $22.51
  • 52 Week High
  • KRYS $207.84
  • TDS $42.74
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 60.39
  • TDS 48.10
  • Support Level
  • KRYS $136.73
  • TDS $38.08
  • Resistance Level
  • KRYS $152.96
  • TDS $41.17
  • Average True Range (ATR)
  • KRYS 5.13
  • TDS 1.03
  • MACD
  • KRYS 0.11
  • TDS -0.14
  • Stochastic Oscillator
  • KRYS 97.23
  • TDS 21.36

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About TDS Telephone and Data Systems Inc.

Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.

Share on Social Networks: